Adaptive Platform Trials
Adaptive Platform Trial is a type of clinical trial design that belongs to the class of longitudinal studies evaluating multiple interventions within a single master protocol, distinguished by its structured adaptability to add or drop treatment arms, modify randomization probabilities, and share control groups over time based on interim Bayesian analyses.
45
Publications
2.5K
Citations
947
Authors
321
Institutions
Publications per year
2017–2026
41
Variants
Adaptive Platform Trial
Parents
45
Derek C. Angus, Scott Berry, Roger Lewis et al. · Annals of the American Thoracic Society · 2020 · 445 citations · Full text
Christopher Butler, Jienchi Dorward, Ly‐Mee Yu et al. · The Lancet · 2021 · 318 citations · Full text
1–5 of 45
947
8
h-index
6
h-index
6
h-index
5
h-index
5
h-index
1–5 of 947
321
Berry & Associates (United States)
Dexter, United States
11 h-index
37 publications
4K citations
University of Oxford
Oxford, United Kingdom
10 h-index
89 publications
7.2K citations
University College London
London, United Kingdom
8 h-index
72 publications
2.8K citations

Vanderbilt University
Nashville, United States
7 h-index
9 publications
471 citations

Monash University
Melbourne, Australia
6 h-index
21 publications
4.5K citations
University of California, San Francisco
San Francisco, United States
5 h-index
24 publications
1.5K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
5 h-index
10 publications
483 citations

University of British Columbia
Vancouver, Canada
5 h-index
9 publications
604 citations
1–8 of 321
5 publications · 457 citations
5
h-index
4 publications · 180 citations
4
h-index
2 publications · 55 citations
2
h-index
2 publications · 62 citations
2
h-index
2 publications · 35 citations
2
h-index
1–5